
WB analysis of various sample lysates using GTX55795 beta Sarcoglycan antibody. Dilution : 1:1000 Loading : 25microg per lane
beta Sarcoglycan antibody
GTX55795
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetSGCB
Overview
- SupplierGeneTex
- Product Namebeta Sarcoglycan antibody
- Delivery Days Customer9
- Application Supplier NoteWB: 1:500 - 1:2000. IHC-P: 1:50 - 1:100. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
- ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- ConjugateUnconjugated
- Gene ID6443
- Target nameSGCB
- Target descriptionsarcoglycan beta
- Target synonymsA3b, LGMD2E, LGMDR4, SGC, beta-sarcoglycan, 43 kDa dystrophin-associated glycoprotein, 43DAG, beta-SG, beta-sarcoglycan(43kD dystrophin-associated glycoprotein), limb girdle muscular dystrophy 2E (non-linked families), sarcoglycan, beta (43kDa dystrophin-associated glycoprotein)
- HostRabbit
- IsotypeIgG
- Protein IDQ16585
- Protein NameBeta-sarcoglycan
- Scientific DescriptionThis gene encodes a member of the sarcoglycan family. Sarcoglycans are transmembrane components in the dystrophin-glycoprotein complex which help stabilize the muscle fiber membranes and link the muscle cytoskeleton to the extracellular matrix. Mutations in this gene have been associated with limb-girdle muscular dystrophy.[provided by RefSeq, Oct 2008]
- ReactivityHuman, Mouse, Rat
- Storage Instruction-20°C or -80°C,2°C to 8°C
- UNSPSC12352203
References
- Perez-Ortiz AC, Peralta-Ildefonso MJ, Lira-Romero E, et al. Lack of Delta-Sarcoglycan (Sgcd) Results in Retinal Degeneration. Int J Mol Sci. 2019,20(21). doi: 10.3390/ijms20215480Read this paper
- Estrada-Mena FJ, Rodriguez A, Mendoza-Lorenzo P, et al. Effects of (-)-epicatechin on frontal cortex DAPC and dysbindin of the mdx mice. Neurosci Lett. 2017,658:142-149. doi: 10.1016/j.neulet.2017.08.056Read this paper










